However, it is unclear at the moment whether increasing FOXF1 levels through nanoparticle gene therapy or recently discovered FOXF1-activating small molecule compound50 will have beneficial effect in human IPF. The gene discussed is FOXF1; the disease is idiopathic pulmonary fibrosis.